Keyphrases
Acute Lymphoblastic Leukemia
100%
Survivors
100%
Neuropathic Pain
100%
Neurocognitive Function
100%
Opioids
60%
California Verbal Learning Test
60%
End of Therapy
40%
Gabapentin
40%
Clinical Trials
20%
Working Diagnosis
20%
Risk Factors
20%
Treatment-related
20%
Adjusted Means
20%
Age-adjusted
20%
Childhood Acute Lymphoblastic Leukemia
20%
At-risk
20%
Re-induction
20%
Memory Performance
20%
Memory Impairment
20%
Contemporary Therapy
20%
Learning Problems
20%
Long Delay
20%
Common Toxicity Criteria
20%
Sustained Learning
20%
Parent Ratings
20%
Neurocognitive Impairment
20%
Cognitive Impairment
20%
Attention Memory
20%
Sustained Attention
20%
Event Severity
20%
Nonpharmacological Pain Management
20%
Neurocognitive Assessment
20%
Learning Performance
20%
Psychosocial Outcomes
20%
Pain Outcomes
20%
Event Duration
20%
Attention Learning
20%
Close Monitoring
20%
Learning Slope
20%
Neurocognitive Deficits
20%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Neuropathic Pain
100%
Opiate
60%
California Verbal Learning Test
60%
Gabapentin
40%
Clinical Trial
20%
Memory Disorder
20%
Learning Disorder
20%
Cognitive Defect
20%
Analgesia
20%
Neuroscience
Neuropathic Pain
100%
California Verbal Learning Test
60%
Opiate
60%
Gabapentin
40%
Learning Disabilities
20%
Memory Disorder
20%
Cognitive Disorders
20%